查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595322

药品可追溯性市场：按类型、最终用户划分 - 2025-2030 年全球预测

Pharmaceutical Traceability Market by Type (Barcode, GPS, RFID), End User (Hospitals, Pharmacies) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年药品追溯市场规模为150.1亿美元，预计2024年将达到184.8亿美元，复合年增长率为23.54%，2030年将达659.9亿美元。

药品可追溯性是指追踪药品的製造、分销和配发的能力。其范围包括旨在打击假药并确保患者安全和监管合规性的序列化、追踪和检验系统。严格的全球监管要求推动了对药品可追溯性的需求，例如美国《药品供应链安全法案》(DSCSA) 和欧盟《假药品指令》(FMD)，这些法规要求药品从生产到销售的整个过程都具有完整的可追溯性。应用程式涵盖整个供应链，从製造商到批发商、药房和医疗保健提供者，提高了透明度和安全性。最终用途主要包括药品製造商、医疗保健分销商、药房和专注于医疗保健提供和安全的政府机构。影响该市场的关键成长要素包括假药的增加、需要透明监控的复杂供应链业务以及区块链和物联网技术的进步以改善追踪和资料完整性。整合高阶分析和人工智慧以获得预测性见解、改善即时决策和物流优化存在机会。然而，高实施成本、资料隐私问题以及不愿采用新系统等挑战可能会阻碍成长。此外，全球监管格局的分散需要一致的合规策略。创新在于制定通用的追溯标准、增强跨境互通性以及利用区块链技术实现不可变记录。进一步探索安全且具成本效益的追溯解决方案以满足地区不同的监管需求也可能刺激成长。市场的动态本质表明技术解决方案不断发展，重点关注永续性和成本效率，这使得它们对寻求在严格法律规范内创新的公司具有广泛的吸引力。

主要市场统计
基准年[2023] 150.1亿美元
预测年份 [2024] 184.8亿美元
预测年份 [2030] 659.9亿美元
复合年增长率（%） 23.54%

市场动态：揭示快速发展的药品追溯市场的关键市场洞察

供需的动态交互作用正在改变药品追溯市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 假药增加
    • 政府对药品的严格监管
    • 药品贸易大幅成长
  • 市场限制因素
    • 解决方案成本高
  • 市场机会
    • 药品追溯智慧解决方案简介
    • 增加策略联盟和投资
  • 市场挑战
    • 缺乏有关药品序列化的通用标准

波特五力：驾驭药品追溯市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解药品追溯市场的外部影响

外部宏观环境因素在塑造药品追溯市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解药品追溯市场的竞争状况

对药品可追溯性市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵药品可追溯市场供应商绩效评估

FPNV 定位矩阵是评估药品追溯市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析并绘製推荐药品追溯市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，药品追溯市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 假药增加
      • 政府对药品的严格监管
      • 药品贸易大幅成长
    • 抑制因素
      • 解决方案高成本
    • 机会
      • 药品追溯智慧解决方案简介
      • 增加策略联盟和投资
    • 任务
      • 药品序号没有通用标准。
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 药品追溯市场：依类型

  • 条码
  • GPS
  • RFID

第七章 药品追溯市场：依最终使用者分类

  • 医院
  • 药局

第八章美洲药品追溯市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太药品追溯市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲药品追溯市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Alien Technology LLC
  • AlpVision SA
  • Authentix Inc.
  • Avery Dennison Corporation
  • Bar Code India Ltd.
  • Cognex Corporation
  • Datalogic SpA
  • Dover Corporation
  • Impinj Inc.
  • Mettler Toledo International Inc.
  • Movilitas Consulting AG
  • Optel Group
  • rfxcel Corp.
  • SATO Holdings Corp.
  • TraceLink Inc.
  • Zebra Technologies Corp.
Product Code: MRR-957C47F90943

The Pharmaceutical Traceability Market was valued at USD 15.01 billion in 2023, expected to reach USD 18.48 billion in 2024, and is projected to grow at a CAGR of 23.54%, to USD 65.99 billion by 2030.

Pharmaceutical traceability refers to the ability to track the production, distribution, and dispensing of pharmaceutical products. Its scope encompasses serialization, tracking, and verification systems designed to combat counterfeit drugs, ensuring patient safety and regulatory compliance. The necessity for pharmaceutical traceability is driven by stringent global regulatory mandates, such as the U.S. Drug Supply Chain Security Act (DSCSA) and the EU Falsified Medicines Directive (FMD), which require full traceability of pharmaceuticals from manufacturing to the point of sale. Applications span across the entire supply chain, from manufacturers to wholesalers, pharmacies, and healthcare providers, enhancing transparency and safety. The end-use scope primarily includes drug manufacturers, healthcare distributors, pharmacies, and governmental agencies focused on healthcare delivery and safety. Key growth factors influencing this market include increasing incidents of counterfeit drugs, complex supply chain operations necessitating transparent oversight, and technological advancements in blockchain and IoT for improved tracking and data integrity. Opportunities exist in the integration of advanced analytics and AI for predictive insights, improving real-time decision-making and optimizing logistics. However, challenges such as high implementation costs, data privacy concerns, and the resistance to adopting new systems may hinder growth. Moreover, the fragmentation of the global regulatory landscape necessitates consistent compliance strategies. Innovation lies in the development of universal traceability standards, enhancing interoperability across borders, and leveraging blockchain technology for immutable records. Additional research into secure yet cost-effective traceability solutions, adapted to varying regional regulatory demands, will also stimulate growth. The market's dynamic nature suggests a constant evolution of technological solutions, with a keen focus on sustainability and cost efficiency, appealing widely to firms seeking to innovate within stringent regulatory frameworks.

KEY MARKET STATISTICS
Base Year [2023] USD 15.01 billion
Estimated Year [2024] USD 18.48 billion
Forecast Year [2030] USD 65.99 billion
CAGR (%) 23.54%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Traceability Market

The Pharmaceutical Traceability Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing presence of counterfeit drugs
    • Strict governmental regulations for pharmaceutical drugs
    • Significant growth in trades of pharmaceutical products
  • Market Restraints
    • High costs of solutions
  • Market Opportunities
    • Introduction of smart solutions for pharmaceutical traceability
    • Increasing strategic alliances and investments
  • Market Challenges
    • Unavailability of general standards for drug serialization

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Traceability Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Traceability Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Traceability Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Traceability Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Traceability Market

A detailed market share analysis in the Pharmaceutical Traceability Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Traceability Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Traceability Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Traceability Market

A strategic analysis of the Pharmaceutical Traceability Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Traceability Market, highlighting leading vendors and their innovative profiles. These include Alien Technology LLC, AlpVision SA, Authentix Inc., Avery Dennison Corporation, Bar Code India Ltd., Cognex Corporation, Datalogic S.p.A., Dover Corporation, Impinj Inc., Mettler Toledo International Inc., Movilitas Consulting AG, Optel Group, rfxcel Corp., SATO Holdings Corp., TraceLink Inc., and Zebra Technologies Corp..

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Traceability Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Barcode, GPS, and RFID.
  • Based on End User, market is studied across Hospitals and Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing presence of counterfeit drugs
      • 5.1.1.2. Strict governmental regulations for pharmaceutical drugs
      • 5.1.1.3. Significant growth in trades of pharmaceutical products
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of smart solutions for pharmaceutical traceability
      • 5.1.3.2. Increasing strategic alliances and investments
    • 5.1.4. Challenges
      • 5.1.4.1. Unavailability of general standards for drug serialization
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Traceability Market, by Type

  • 6.1. Introduction
  • 6.2. Barcode
  • 6.3. GPS
  • 6.4. RFID

7. Pharmaceutical Traceability Market, by End User

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Pharmacies

8. Americas Pharmaceutical Traceability Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Pharmaceutical Traceability Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Pharmaceutical Traceability Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alien Technology LLC
  • 2. AlpVision SA
  • 3. Authentix Inc.
  • 4. Avery Dennison Corporation
  • 5. Bar Code India Ltd.
  • 6. Cognex Corporation
  • 7. Datalogic S.p.A.
  • 8. Dover Corporation
  • 9. Impinj Inc.
  • 10. Mettler Toledo International Inc.
  • 11. Movilitas Consulting AG
  • 12. Optel Group
  • 13. rfxcel Corp.
  • 14. SATO Holdings Corp.
  • 15. TraceLink Inc.
  • 16. Zebra Technologies Corp.

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL TRACEABILITY MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL TRACEABILITY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. PHARMACEUTICAL TRACEABILITY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. PHARMACEUTICAL TRACEABILITY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL TRACEABILITY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL TRACEABILITY MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY BARCODE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY GPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY RFID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. PHARMACEUTICAL TRACEABILITY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. PHARMACEUTICAL TRACEABILITY MARKET, FPNV POSITIONING MATRIX, 2023